BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 11566016)

  • 21. Determinants of satisfactory rigidity after intracavernosal injection with prostaglandin E1 in men with erectile failure.
    Purvis K; Brekke I; Christiansen E
    Int J Impot Res; 1996 Mar; 8(1):9-16. PubMed ID: 8735188
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intraurethral alprostadil for impotence.
    Med Lett Drugs Ther; 1997 Mar; 39(997):32. PubMed ID: 9121395
    [No Abstract]   [Full Text] [Related]  

  • 23. Transurethral alprostadil with MUSE (medicated urethral system for erection) vs intracavernous alprostadil--a comparative study in 103 patients with erectile dysfunction.
    Lewis RW
    Int J Impot Res; 1998 Mar; 10(1):61-2. PubMed ID: 9542692
    [No Abstract]   [Full Text] [Related]  

  • 24. Re: Disappointing initial results with transurethral alprostadil for erectile dysfunction in a urology practice setting.
    Hellstrom WJ; Lewis RW
    J Urol; 1999 Oct; 162(4):1390. PubMed ID: 10492215
    [No Abstract]   [Full Text] [Related]  

  • 25. Re: Disappointing initial results with transurethral alprostadil for erectile dysfunction in a urology practice setting.
    Subramonian K; Weston PM
    J Urol; 1999 Jul; 162(1):168-9. PubMed ID: 10379774
    [No Abstract]   [Full Text] [Related]  

  • 26. Long-term efficacy and compliance of MUSE for erectile dysfunction following radical prostatectomy: SHIM (IIEF-5) analysis.
    Raina R; Agarwal A; Zaramo CE; Ausmundson S; Mansour D; Zippe CD
    Int J Impot Res; 2005; 17(1):86-90. PubMed ID: 15526008
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Prostaglandin in the treatment of impotence].
    Tammela T
    Duodecim; 1998; 114(4):371-5. PubMed ID: 11466950
    [No Abstract]   [Full Text] [Related]  

  • 28. Intracavernous injection of alprostadil for erectile dysfunction.
    Med Lett Drugs Ther; 1995 Sep; 37(958):83-4. PubMed ID: 7674992
    [No Abstract]   [Full Text] [Related]  

  • 29. Effects of alprostadil and prazosin on motility, viability and membrane integrity of human sperm.
    Hellstrom WJ; Wang R; Peterson CA; Varady JC; Gesundheit N; Sikka SC
    J Urol; 1998 May; 159(5):1559-62. PubMed ID: 9554354
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Pharmacological therapy of erectile dysfunction].
    Becker AJ; Stief CG; Schultheiss D; Truss MC; Jonas U
    Urologe A; 1998 Sep; 37(5):503-8. PubMed ID: 9796031
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Review of intraurethral suppositories and iontophoresis therapy for erectile dysfunction.
    Lewis R
    Int J Impot Res; 2000 Oct; 12 Suppl 4():S86-90. PubMed ID: 11035393
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Does alprostadil cream hit the spot?
    Drug Ther Bull; 2015 Feb; 53(2):21-4. PubMed ID: 25678352
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transurethral alprostadil for the treatment of erectile dysfunction: results of a multicentre trial.
    Li MK; Lim PH; Wong MY; Fok A; Chia SJ; Consigliere D; Adaikan PG; Moorthy P
    Ann Acad Med Singap; 2000 Nov; 29(6):727-31. PubMed ID: 11269978
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An overview and expert opinion on the use of alprostadil in the treatment of sexual dysfunction.
    Costabile RA; Mammen T; Hwang K
    Expert Opin Pharmacother; 2008 Jun; 9(8):1421-9. PubMed ID: 18473716
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alprostadil for the treatment of impotence.
    Hanchanale V; Eardley I
    Expert Opin Pharmacother; 2014 Feb; 15(3):421-8. PubMed ID: 24369066
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment for impotence gains FDA approval.
    Am J Health Syst Pharm; 1995 Oct; 52(19):2078-9. PubMed ID: 8535938
    [No Abstract]   [Full Text] [Related]  

  • 37. Special precautions to be observed while using alprostadil in patients with spinal cord injury.
    Vaidyanathan S; Soni BM; Krishnan KR
    Spinal Cord; 1997 Jun; 35(6):402-3. PubMed ID: 9194266
    [No Abstract]   [Full Text] [Related]  

  • 38. Alprostadil for impotence.
    Boyde TR
    Lancet; 1998 Mar; 351(9104):757. PubMed ID: 9504550
    [No Abstract]   [Full Text] [Related]  

  • 39. Intraurethral and topical agents.
    Lewis RW
    Drugs Today (Barc); 2000; 36(2-3):113-9. PubMed ID: 12879108
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aviptadil (Senatek).
    Keijzers GB
    Curr Opin Investig Drugs; 2001 Apr; 2(4):545-9. PubMed ID: 11566015
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.